Do you know anyone suffering from psoriasis? Call Today – 855.554.6374
note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
Clinical Trial Government Identifier #NCT03624127
Sponsor: Bristol-Myers Squibb
|Genders eligible for study: Male/Female||Ages eligible for study: 18 and older|
|NEW STUDY – NOW ENROLLING – Moderate to Severe plaque psoriasis present for at least 6 months; no prior use of apremilast allowed||July 2018 – July 2020|
Don’t qualify? Check out our other clinical trials for psoriasis.